|
1
|
Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy.
|
N Engl J Med
|
1992
|
3.91
|
|
2
|
A controlled trial of acyclovir for chickenpox in normal children.
|
N Engl J Med
|
1991
|
3.78
|
|
3
|
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
|
J Pediatr
|
1981
|
3.42
|
|
4
|
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.
|
Antimicrob Agents Chemother
|
1992
|
3.31
|
|
5
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era.
|
Pediatrics
|
2001
|
2.91
|
|
6
|
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.
|
J Virol
|
1995
|
2.87
|
|
7
|
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.
|
J Virol
|
1992
|
2.80
|
|
8
|
Intrauterine infection with varicella-zoster virus after maternal varicella.
|
N Engl J Med
|
1986
|
2.63
|
|
9
|
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
|
J Virol
|
1998
|
2.48
|
|
10
|
Varicella vaccine in pregnancy.
|
BMJ
|
1996
|
2.38
|
|
11
|
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.
|
J Virol
|
1997
|
2.34
|
|
12
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
|
Pediatrics
|
2001
|
2.30
|
|
13
|
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
|
Proc Natl Acad Sci U S A
|
1998
|
2.22
|
|
14
|
Reliability of a history of previous varicella infection in adults.
|
JAMA
|
1997
|
2.13
|
|
15
|
Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
|
N Engl J Med
|
1987
|
1.99
|
|
16
|
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.
|
Virology
|
2000
|
1.99
|
|
17
|
Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.
|
N Engl J Med
|
1986
|
1.94
|
|
18
|
Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
|
J Infect Dis
|
2001
|
1.90
|
|
19
|
Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
|
JAMA
|
1998
|
1.83
|
|
20
|
Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression.
|
J Infect Dis
|
2000
|
1.81
|
|
21
|
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.
|
J Infect Dis
|
1986
|
1.72
|
|
22
|
Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.
|
N Engl J Med
|
1988
|
1.67
|
|
23
|
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
|
J Infect Dis
|
1996
|
1.66
|
|
24
|
Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody.
|
Infect Immun
|
1983
|
1.65
|
|
25
|
Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.
|
J Virol
|
1989
|
1.64
|
|
26
|
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument.
|
J Virol
|
2001
|
1.55
|
|
27
|
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
|
J Virol
|
2001
|
1.53
|
|
28
|
Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients.
|
J Infect Dis
|
1978
|
1.51
|
|
29
|
Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
|
J Clin Invest
|
1980
|
1.48
|
|
30
|
The management of pregnancies complicated by genital infections with herpes simplex virus.
|
Clin Infect Dis
|
1992
|
1.45
|
|
31
|
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
|
J Infect Dis
|
1991
|
1.43
|
|
32
|
Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
|
J Clin Microbiol
|
1980
|
1.41
|
|
33
|
Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma.
|
J Infect Dis
|
1978
|
1.40
|
|
34
|
Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.
|
J Virol
|
2001
|
1.36
|
|
35
|
Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
|
J Virol
|
2000
|
1.30
|
|
36
|
Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
|
J Infect Dis
|
1988
|
1.29
|
|
37
|
IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants.
|
J Immunol
|
1999
|
1.28
|
|
38
|
Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
|
J Infect Dis
|
1992
|
1.26
|
|
39
|
Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery.
|
J Infect Dis
|
1990
|
1.17
|
|
40
|
Fusarium brain abscess. Case report.
|
J Neurosurg
|
1983
|
1.17
|
|
41
|
Immunologic evidence of reinfection with varicella-zoster virus.
|
J Infect Dis
|
1983
|
1.16
|
|
42
|
T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
|
J Immunol
|
1989
|
1.15
|
|
43
|
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
|
J Immunol
|
1986
|
1.15
|
|
44
|
Relationship of antibody to outcome in neonatal herpes simplex virus infections.
|
Infect Immun
|
1980
|
1.12
|
|
45
|
Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
|
J Infect Dis
|
1989
|
1.08
|
|
46
|
Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial.
|
Antimicrob Agents Chemother
|
1978
|
1.08
|
|
47
|
Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus.
|
Pediatrics
|
1984
|
1.08
|
|
48
|
Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants.
|
J Infect Dis
|
1976
|
1.06
|
|
49
|
Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
|
J Infect Dis
|
1987
|
1.06
|
|
50
|
Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
|
Am J Obstet Gynecol
|
1991
|
1.05
|
|
51
|
Varicella-zoster virus infection of a human CD4-positive T-cell line.
|
Virology
|
2000
|
1.04
|
|
52
|
The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995.
|
J Infect Dis
|
1999
|
1.04
|
|
53
|
Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus.
|
J Infect Dis
|
1998
|
1.04
|
|
54
|
Human leukocyte interferon for the treatment of varicella in children with cancer.
|
N Engl J Med
|
1982
|
1.02
|
|
55
|
Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.
|
J Infect Dis
|
1992
|
1.02
|
|
56
|
Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine.
|
J Infect Dis
|
1997
|
1.01
|
|
57
|
Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells.
|
J Virol
|
2000
|
1.00
|
|
58
|
Neonatal herpes simplex infection in the absence of mucocutaneous lesions.
|
J Pediatr
|
1982
|
1.00
|
|
59
|
Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine.
|
J Infect Dis
|
1998
|
0.99
|
|
60
|
Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children.
|
J Clin Microbiol
|
1990
|
0.99
|
|
61
|
Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids.
|
J Infect Dis
|
1998
|
0.98
|
|
62
|
Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients.
|
Am J Med
|
1982
|
0.98
|
|
63
|
Immune evasion as a pathogenic mechanism of varicella zoster virus.
|
Semin Immunol
|
2001
|
0.97
|
|
64
|
Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
|
J Gen Virol
|
1992
|
0.96
|
|
65
|
Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity.
|
J Infect Dis
|
1998
|
0.95
|
|
66
|
Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
|
J Immunol
|
1997
|
0.92
|
|
67
|
Genital herpes and the pregnant woman.
|
Curr Clin Top Infect Dis
|
1989
|
0.91
|
|
68
|
Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
|
J Clin Microbiol
|
1983
|
0.91
|
|
69
|
T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
|
J Infect Dis
|
1996
|
0.90
|
|
70
|
Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction.
|
J Infect Dis
|
1993
|
0.90
|
|
71
|
Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
|
J Infect Dis
|
1995
|
0.90
|
|
72
|
Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells.
|
Viral Immunol
|
2001
|
0.89
|
|
73
|
Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster).
|
J Clin Microbiol
|
1986
|
0.87
|
|
74
|
Herpes simplex virus type 2--a persistent problem.
|
N Engl J Med
|
1997
|
0.86
|
|
75
|
Pharmacokinetics of acyclovir suspension in infants and children.
|
Antimicrob Agents Chemother
|
1987
|
0.86
|
|
76
|
Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.
|
J Virol
|
1991
|
0.86
|
|
77
|
The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
|
J Infect Dis
|
1990
|
0.86
|
|
78
|
Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
|
Viral Immunol
|
1991
|
0.85
|
|
79
|
Interferon prophylaxis against simian varicella in Erythrocebus patas monkeys.
|
J Infect Dis
|
1983
|
0.85
|
|
80
|
Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.
|
Pediatr Infect Dis J
|
1996
|
0.84
|
|
81
|
A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy.
|
Pediatr Infect Dis J
|
1990
|
0.84
|
|
82
|
Nocardia farcinica pneumonia in chronic granulomatous disease.
|
Pediatrics
|
1999
|
0.83
|
|
83
|
Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
|
J Immunol
|
1999
|
0.83
|
|
84
|
Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
|
J Infect Dis
|
1988
|
0.83
|
|
85
|
Neonatal aspergillosis. A case report and review of the literature.
|
Clin Pediatr (Phila)
|
1986
|
0.82
|
|
86
|
Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2.
|
Clin Diagn Virol
|
1993
|
0.82
|
|
87
|
Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides.
|
J Infect Dis
|
1998
|
0.82
|
|
88
|
Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.
|
J Pediatr
|
1984
|
0.82
|
|
89
|
Acid labile alpha-interferon in sera and synovial fluids from patients with juvenile arthritis.
|
Arthritis Rheum
|
1984
|
0.81
|
|
90
|
The effect of chronologic age on the serum concentrations of amikacin in sick term and premature infants.
|
J Pediatr
|
1981
|
0.81
|
|
91
|
Human monoclonal antibodies neutralizing varicella-zoster virus.
|
J Infect Dis
|
1985
|
0.81
|
|
92
|
Varicella vaccine--the first six years.
|
N Engl J Med
|
2001
|
0.81
|
|
93
|
Perinatal viral infections.
|
Eur J Clin Microbiol
|
1987
|
0.80
|
|
94
|
Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella.
|
J Med Virol
|
1994
|
0.80
|
|
95
|
Multifocal leukoencephalitis caused by varicella-zoster virus in a child with leukemia: successful treatment with acyclovir.
|
Pediatr Infect Dis J
|
1993
|
0.80
|
|
96
|
Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.
|
Pediatr Infect Dis J
|
1989
|
0.80
|
|
97
|
Treatment of adult varicella with sorivudine: a randomized, placebo-controlled trial.
|
J Infect Dis
|
1996
|
0.79
|
|
98
|
Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.
|
J Virol
|
1993
|
0.79
|
|
99
|
A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery.
|
Pediatr Infect Dis J
|
1989
|
0.79
|
|
100
|
Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
|
Pediatrics
|
1991
|
0.79
|
|
101
|
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
|
J Infect Dis
|
1992
|
0.78
|
|
102
|
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
|
Am J Med
|
1984
|
0.78
|
|
103
|
Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
|
J Gen Virol
|
1984
|
0.78
|
|
104
|
Alpha interferon administration to infants with congenital rubella.
|
Antimicrob Agents Chemother
|
1982
|
0.77
|
|
105
|
Oral therapy with acyclovir in infants and children.
|
Pediatr Infect Dis J
|
1987
|
0.77
|
|
106
|
Serological investigation of an outbreak of simian varicella in Erythrocebus patas monkeys.
|
J Clin Microbiol
|
1983
|
0.77
|
|
107
|
Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
|
Antiviral Res
|
1999
|
0.77
|
|
108
|
Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.
|
Antimicrob Agents Chemother
|
1981
|
0.76
|
|
109
|
Measles vaccines--a positive step toward eradicating a negative strand.
|
Nat Med
|
2000
|
0.75
|
|
110
|
Neonatal herpes simplex encephalitis: correlation of clinical and CT findings.
|
Radiology
|
1987
|
0.75
|
|
111
|
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on proliferation of human fibroblasts, peripheral blood mononuclear cells, and granulocyte-monocyte progenitor cells in vitro.
|
Antimicrob Agents Chemother
|
1983
|
0.75
|
|
112
|
Urinary tract infections--navigating complex currents.
|
West J Med
|
1992
|
0.75
|
|
113
|
The validity of reporting results of cultures for herpes simplex virus after four days.
|
J Reprod Med
|
1982
|
0.75
|
|
114
|
Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.
|
IARC Sci Publ
|
1978
|
0.75
|
|
115
|
Consensus: management of the patient with herpes simplex encephalitis.
|
Pediatr Infect Dis J
|
1987
|
0.75
|
|
116
|
Serologic misdiagnosis of congenital infections.
|
Pediatr Infect Dis J
|
1989
|
0.75
|
|
117
|
Varicella zoster virus antibody titers before and after administration of zoster immune globulin to neonates in an intensive care nursery.
|
J Pediatr
|
1983
|
0.75
|
|
118
|
The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
|
Antiviral Res
|
1997
|
0.75
|
|
119
|
Interferon as an antiviral and anti-tumor therapeutic agent.
|
Ophthalmology
|
1980
|
0.75
|
|
120
|
Intravenous ribavirin therapy for adenovirus pneumonia.
|
Pediatr Pulmonol
|
2000
|
0.75
|